Fresenius | FRE - Market Capitalization


Fresenius reported EUR26.28B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akzo Nobel EUR 10.15B 1.73B Jun/2026
Alcon AG USD 37.06B 5.98B Mar/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
BASF EUR 41.75B 5.02B Jun/2026
Bayer EUR 49.51B 10.82B Aug/2026
Beiersdorf EUR 22.73B 3.43B Dec/2025
DaVita Healthcare Partners USD 18.69B 8.43B Aug/2026
Demant DKK 46.01B 10.48B Dec/2025
E.ON EUR 49.57B 6.98B Mar/2026
Essilor EUR 76.16B 48.88B Jun/2026
Fresenius EUR 26.24B 3.72B Aug/2026
Fresenius Medical Care EUR 11.32B 642.58M Mar/2026
Getinge SEK 53.96B 1.2B Jun/2026
Givaudan CHF 29.05B 6.42B Dec/2025
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GN Store Nord DKK 15.22B 890.39M Mar/2026
GRIFOLS EUR 4.25B 1.16B Aug/2026
Hikma Pharmaceutical USD 3.49B 1.14B Aug/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 46.78B 6.52B Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Philips EUR 23.09B 615.44M Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
RWE EUR 42.9B 9.24B Mar/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Smith & Nephew USD 3.54B 9.16B Aug/2026